Infection with the influenza virus leads to lung injury through inflammation over-activation that causes collateral damage to cells required for breathing.
Findings show a newly created drug can prevent runaway inflammation while still allowing the immune system to handle the virus, even when given late into infect
Findings show a newly created drug can prevent runaway inflammation while still allowing the immune system to handle the virus, even when given late into infect